Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Introduction To Survival Analysis01:18

Introduction To Survival Analysis

Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time until a...
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
Genomics02:02

Genomics

Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Early Phase Dose-Finding Designs for CAR-T Cell Therapies.

Pharmaceutical statistics·2026
Same author

Ischaemic stroke and 5-fluorouracil or capecitabine: A systematic review and meta-analysis of harms and a retrospective study of the WHO pharmacovigilance database.

British journal of pharmacology·2026
Same author

Efficacy of buparlisib according to PIK3CA mutation status in recurrent or metastatic head and neck squamous cell carcinoma: A multicenter phase II trial.

Oral oncology·2026
Same author

Impact of Neoadjuvant Chemotherapy Administration Time of Day on Pathological Response in Patients with Early Triple-Negative Breast Cancer.

Cancers·2026
Same author

Phase 1b study of ABBV-368, tilsotolimod, budigalimab, and nab-paclitaxel in patients with recurrent/metastatic head and neck squamous cell carcinoma.

Journal for immunotherapy of cancer·2026
Same author

CMV seropositivity associates with poor clinical outcome in triple negative breast cancer.

iScience·2026

Related Experiment Video

Updated: May 21, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

Multi-omics data integration using time-to event endpoint and supervised Cox penalized regression: a comprehensive

Antoine Dubray-Vautrin1,2,3, Christophe Le Tourneau4,5, Jimmy Mullaert4

  • 1Institut Curie, PSL Research University, INSERM, U1331, Saint Cloud, France. antoine.dubrayvautrin@curie.fr.

Clinical and Experimental Medicine
|May 20, 2026
PubMed
Summary

Integrating multi-omics data improves cancer prognostication, but challenges remain. This review explores variable selection and regularization methods for building accurate predictive models from complex, high-dimensional omics data for survival outcomes.

Keywords:
Head and neckHigh-dimensional statisticsIntegrative analysisOmics: RegularizationSurvival modeling

More Related Videos

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

Related Experiment Videos

Last Updated: May 21, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

Area of Science:

  • Biomedical Informatics
  • Computational Biology
  • Genomic Medicine

Background:

  • Multi-omics data integration (genomics, transcriptomics, epigenomics, proteomics) offers comprehensive insights into complex diseases like cancer.
  • Multi-omics prognostic models enhance patient stratification and personalized prognostication.
  • High dimensionality, heterogeneity, and correlations in omics data present significant challenges for predictive modeling, especially in time-to-event analyses.

Purpose of the Study:

  • To review and synthesize current methodologies for variable selection and regularization in high-dimensional omics data.
  • To focus on the application of these methods to survival outcomes in complex diseases.
  • To discuss the trade-offs between interpretability, computational efficiency, and predictive performance of different approaches.

Main Methods:

  • Exploration of global penalty approaches (LASSO, Ridge, Elastic Net) for model complexity control.
  • Analysis of parallel regression methods for independent omics layer analysis.
  • Examination of group regularization (Group LASSO, OSCAR) and hierarchical regression (Priority LASSO, IPF-LASSO) for multicollinearity and prior knowledge integration.
  • Review of kernel-based methods (KEN-COX) for nonlinear relationships and dimensionality reduction.

Main Results:

  • Various methods offer distinct advantages and disadvantages regarding interpretability, computational efficiency, and predictive performance.
  • Global penalty methods control complexity; parallel methods offer robustness but may miss correlations.
  • Group and hierarchical methods enhance interpretability and handle multicollinearity, while kernel methods address nonlinearity.

Conclusions:

  • Tailored approaches are needed to balance interpretability, efficiency, and performance in multi-omics survival modeling.
  • Model transparency and clinical applicability are crucial for successful implementation.
  • Future research should refine techniques to better capture the complex interplay of omics data in disease progression and survival.